Evommune, Inc. SEC filings EVMN
Evommune, Inc. has 138 filings in SEC EDGAR's recent list, going back to Jan 7, 2025. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Apr 24, 2026 | — |
| CORRESP | Letter to the SEC | Apr 22, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 22, 2026 | — |
| CERT | Nyse certification | Nov 5, 2025 | — |
| 8-A12B | Filing | Nov 4, 2025 | — |
| DRS/A | Filing | Sep 23, 2025 | — |
| DRSLTR | Filing | Sep 22, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2025 | — |
| DRS/A | Filing | Sep 2, 2025 | — |
| DRSLTR | Filing | Aug 29, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 30, 2025 | — |
| DRSLTR | Filing | Jul 18, 2025 | — |
| DRS/A | Filing | Jul 18, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 10, 2025 | — |
| DRS | Filing | May 14, 2025 | — |
| D | Filing | Jan 8, 2025 | — |
| D | Filing | Jan 8, 2025 | — |
| D | Filing | Jan 8, 2025 | — |
| D | Filing | Jan 7, 2025 | — |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- EVMN (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Palo Alto, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2044725
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.